Patents for A61P 35 - Antineoplastic agents (221,099)
12/2009
12/23/2009CN101607979A Pentacylic triterpanes-vitamin C conjugates as well as preparation method and medical application thereof
12/23/2009CN101607978A Two novel compounds in gamboge, preparation method and pharmaceutical use
12/23/2009CN101607958A Quinazoline compounds
12/23/2009CN101607942A Novel imidazolone anti-tumor compound and preparation method thereof
12/23/2009CN101607938A Novel isoquinoline anti-tumor compound and preparation method thereof
12/23/2009CN101607936A Gimeracil crystal form and preparation method thereof
12/23/2009CN101607931A Preparation method of calcitriol
12/23/2009CN101607913A 改进的螯合剂缀合物 Improved chelator conjugate
12/23/2009CN101607886A Novel wool gonane compound as well as preparation method and anticancer purpose thereof
12/23/2009CN101607861A Method for preparing anti-cancer drug elemene from radix curcumae
12/23/2009CN101607091A Method for synthesizing dextran-magnetic LDH-fluorouracil magnetic targeting sustained and controlled release tripolymer
12/23/2009CN101607087A Combinations of dmxaa and other anti-cancer agents
12/23/2009CN101607068A Traditional Chinese medicine pro-liposome injection for treating liver cancer and preparation process thereof
12/23/2009CN101607012A Medicine for treating tumor and cancer and preparation method thereof
12/23/2009CN101606976A Method for preparing tetrandrine alkaloids by coupling in-situ conversion-adsorptive separation technology
12/23/2009CN101606963A Traditional Chinese medicine combination for enhancing disintoxication and improving dyscrasia of cancer patients
12/23/2009CN101606957A Formula for treating and preventing arthritis, synovitis and other orthopaedic diseases and complicating diseases
12/23/2009CN101606948A Application of small interfering RNA in preparing medicament for treating colon cancer
12/23/2009CN101606947A Gemcitabine hydrochloride composition and preparation method thereof
12/23/2009CN101606934A Bendamustine hydrochloride compound
12/23/2009CN101606933A Dihydro porphin photosensitizer, preparation method and application thereof
12/23/2009CN101606907A Fotemustine solid lipid nanoparticle and preparation method thereof
12/23/2009CN100572542C Systemic viral/ligand gene delivery system and gene therapy
12/23/2009CN100572540C Tuberculosis vaccines including recombinant BCG strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase
12/23/2009CN100572530C Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitro
12/23/2009CN100572399C Ultramicro chito polysaccharide product processing method
12/23/2009CN100572382C Heterocyclic compound capable of inversing tumor cell drug tolerance, preparation method and application thereof
12/23/2009CN100572363C New imidazole derivative, method for producing the same and use of the same
12/23/2009CN100571785C Relativity between AnnexinA3 and drug resistance of platinum type chemical curing medication for cancer
12/23/2009CN100571781C Biotinylated pulullan polysaccharide nanometer grains and the preparation method
12/23/2009CN100571709C Medicinal composition with anti-tumor synergistic effect
12/23/2009CN100571699C Selenophen compound for treating cancer and its medicine composition
12/23/2009CN100571698C Extract of valid target in cudrania tricuspidata total flavone and method for preparing the same
12/23/2009CN100571691C Antineoplastic patches for external use of bullatacin
12/23/2009CN100571681C Zedoary oil nano emulsion and its preparation process
12/23/2009CN100571680C Preparation method of compound bitter sophora preparation for injection and medical use thereof
12/23/2009CN100571540C Coco alkaline having carcinogenesis suppressing function
12/23/2009CA2728976A1 Combinations comprising methotrexate and dhodh inhibitors
12/23/2009CA2728763A1 Crkl targeting peptides
12/23/2009CA2728739A1 Compositions, methods, and kits for eliciting an immune response
12/23/2009CA2728459A1 Immunogenic peptides derived from the midkine protein, as an anticancer vaccine
12/23/2009CA2728454A1 Thiazolyl- and oxazolyl-isoquinolinones and methods for using them
12/23/2009CA2728408A1 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
12/23/2009CA2728276A1 Combination therapies against cancer
12/23/2009CA2728268A1 Cdca1 epitope peptides and vaccines containing the same
12/23/2009CA2728194A1 3-(3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives as met kinase inhibitors
12/23/2009CA2728183A1 Compositions with and process for methylmorpholin-substituted pyrido [2,3-d] pryimidines
12/23/2009CA2728063A1 Pyrazole compounds 436
12/23/2009CA2727928A1 Inhibitors of janus kinases
12/23/2009CA2727889A1 Anti-tumour compositions and methods
12/23/2009CA2727862A1 Boronate ester compounds and pharmaceutical compositions thereof
12/23/2009CA2727251A1 2 -arylaminoquinazolines for treating proliferative diseases
12/23/2009CA2727069A1 Thiophene or thiazole derivatives and their use as pi3k inhibitors
12/23/2009CA2727036A1 Triazolopyridine jak inhibitor compounds and methods
12/23/2009CA2726844A1 Triazolopyridine jak inhibitor compounds and methods
12/23/2009CA2726508A1 Pyridine compounds
12/23/2009CA2726164A1 Wnt protein signalling inhibitors
12/23/2009CA2725911A1 Methods of treating a meiotic kinesin-associated disease
12/23/2009CA2725014A1 Inhibitors of pi3 kinase
12/23/2009CA2723279A1 3-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
12/22/2009US7635774 Benzimidazole derivatives
12/22/2009US7635769 Oligoribonucleotide derivatives for specific inhibition of gene expression
12/22/2009US7635767 Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same
12/22/2009US7635757 Nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro
12/22/2009US7635712 Salinosporamides and methods for use thereof
12/22/2009US7635708 Peroxidase proliferator activated receptor (PPAR) gamma agonists for playing key role in inducing growth arrest by terminal differentiation of actively proliferating PPAR gamma-expressing cells, particularly transformed adipose cells
12/22/2009US7635702 Imidazole compounds as transforming growth factor (TGF) inhibitors
12/22/2009US7635686 Cancer treatment with a synthetic sequences
12/22/2009US7635677 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells
12/22/2009US7635673 Gene expression inhibition via contacting with tyrphostin; liposomes; drug screening
12/22/2009US7635556 Methods for drug discovery, disease treatment, and diagnosis using metabolomics
12/22/2009US7635479 comprising fusion protein biodrug as antitumor agent; contains amino acid sequence from prokaryotic organism such as a Listeria species protein, an ActA protein, a Streptolysin protein; immunotherapy
12/22/2009US7635475 Diabody-type bispecific antibody
12/22/2009US7635472 single chain antibody construct comprising binding domains specific for human CD3 and human CD19; anticarcinogenic biodrug for treating non-Hodgkin lymphoma
12/22/2009US7635468 Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine
12/22/2009US7635467 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
12/22/2009US7635464 Selective targeting of apoptotic cells
12/22/2009CA2627862C Use of inhibitors of dipeptidyl peptidase iv (dp iv) in combination with inhibitors of alanyl-aminopeptidase (apn)
12/22/2009CA2567857C Irinotecan liposome formulation
12/22/2009CA2538095C Selective androgen receptor modulators and methods of use thereof
12/22/2009CA2535614C Quinazoline analogs as receptor tyrosine kinase inhibitors
12/22/2009CA2479674C New therapeutic use of 5-aminoimidazole-4-carboxamide riboside (acadesine)
12/22/2009CA2462369C Compositions for delivery of drug combinations
12/22/2009CA2454799C Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
12/22/2009CA2435921C Method of cancer therapy
12/22/2009CA2417282C Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid
12/22/2009CA2416527C Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
12/22/2009CA2406081C Administration of a thiol-based chemoprotectant compound
12/22/2009CA2402421C Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals
12/22/2009CA2371712C Cyclothiocarbamate derivatives as progesterone receptor modulators
12/22/2009CA2369587C Solubilized pharmaceutical composition for parenteral administration
12/22/2009CA2368108C Thienopyrimidine compounds, their production and use
12/22/2009CA2354024C A recombinant vector expressing multiple costimulatory molecules and uses thereof
12/22/2009CA2347752C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
12/22/2009CA2346847C Novel imidazoles with anti-inflammatory activity
12/22/2009CA2345297C Synthetic analogs of ecteinascidin-743
12/22/2009CA2330976C Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents
12/22/2009CA2173839C Transferrin compositions to alleviate the side effects of cytotoxic drugs
12/22/2009CA2133833C Method and kit for imaging and treating organs and tissues
12/20/2009WO2009156041A2 Thiazolyl piperdine derivatives